The novel cyclooxygenase-2 inhibitor GW637185X protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity

被引:8
作者
Aguirre, Jose A. [1 ]
Leo, Giuseppina [3 ]
Cueto, Raquel [2 ]
Andbjer, Beth [4 ]
Naylor, Alan [5 ]
Medhurst, Andrew D. [5 ]
Agnati, Luigi F. [3 ]
Fuxe, Kjell [4 ]
机构
[1] Univ Malaga, Sch Med, Dept Human Physiol, E-29071 Malaga, Spain
[2] Univ Malaga, Sch Med, Dept Pharmacol, E-29071 Malaga, Spain
[3] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy
[4] Karolinska Inst, Dept Neurosci, Stockholm, Sweden
[5] GlaxoSmithKline, Neurol GI, Ctr Excellence Drug Discovery, Harlow, Essex, England
关键词
basal ganglia; cyclooxygenase-2 inhibitor GW637185X; microdensitometry; mouse; neuroprotection; Parkinson's disease; stereology tyrosine hydroxylase; 1-methyl-4-phenyl-1; 2; 3; 6-tetrahydropyridine;
D O I
10.1097/WNR.0b013e3282fb7898
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The possible neuroprotective role of a novel and highly selective cyclooxygenase-2 inhibitor GW637185X was studied in a model of acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced injury of nigrostriatal dopaminergic (DA) neurons in the mouse. Stereological and microdensitometrical analysis of nigral tyrosine hydroxylase-immunoreactive cell bodies and striatal tyrosine hydroxylase-immunoreactive terminals, respectively, showed that GW637185X exerted a full protection against MPTP-induced degeneration of the nigro-striatal pathway. In contrast to earlier studies, these findings demonstrate that acute inhibition of cyclooxygenase-2 can result in a full neuroprotective effect not only on nigral DA cell bodies, but also on striatal DA terminals in the mouse MPTP model.
引用
收藏
页码:657 / 660
页数:4
相关论文
共 26 条
[1]  
AGNATI LF, 1984, ACTA PHYSIOL SCAND, P5
[2]   Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP [J].
Aguirre, JA ;
Kehr, J ;
Yoshitake, T ;
Liu, FL ;
Rivera, A ;
Fernandez-Espinola, S ;
Andbjer, B ;
Leo, G ;
Medhurst, AD ;
Agnati, LF ;
Fuxe, K .
BRAIN RESEARCH, 2005, 1033 (02) :216-220
[3]  
AGUIRRE JA, 2007, 7 IBRO WORLD C NEUR, P337
[4]   Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity [J].
Araki, E ;
Forster, C ;
Dubinsky, JM ;
Ross, ME ;
Iadecola, C .
STROKE, 2001, 32 (10) :2370-2375
[5]  
Brambilla R, 2001, ANN NY ACAD SCI, V939, P54
[6]   Differential effects of acute and subchronic administration on phencyclidine-induced neuro degeneration in the perinatal rat [J].
Cheng, ZW ;
Johnson, KM .
JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 81 (02) :284-292
[7]   COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice [J].
Feng, ZH ;
Li, DD ;
Fung, PCW ;
Pei, Z ;
Ramsden, DB ;
Ho, SL .
NEUROREPORT, 2003, 14 (15) :1927-1929
[8]   Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra [J].
Feng, ZH ;
Wang, TG ;
Li, DD ;
Fung, P ;
Wilson, BC ;
Liu, B ;
Ali, SF ;
Langenbach, R ;
Hong, JS .
NEUROSCIENCE LETTERS, 2002, 329 (03) :354-358
[9]  
GREEN RH, 2001, Patent No. 0138311
[10]  
Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214